上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
Curcumenol (Synonyms: (+)-Curcumenol) 纯度: ≥99.0%
Curcumenol 是高效的 CYP3A4 抑制剂,IC50 值为 12.6 μM,是一种具有药用价值的 Curcuma zedoaria 的重要提取物,具有神经保护、抗炎、抗肿瘤和保肝活性。Curcumenol ((+)-Curcumenol) 在 LPS 刺激的 BV-2 小胶质细胞中,抑制 Akt 介导的 NF-κB 活化和 p38 MAPK 信号通路。

Curcumenol Chemical Structure
CAS No. : 19431-84-6
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
5 mg | ¥900 | In-stock | |
10 mg | ¥1400 | In-stock | |
25 mg | ¥2800 | In-stock | |
100 mg | ¥7000 | In-stock | |
200 mg | 询价 | ||
500 mg | 询价 |
* Please select Quantity before adding items.
Curcumenol 相关产品
•相关化合物库:
- Covalent Screening Library Plus
- Natural Product Library Plus
- Bioactive Compound Library Plus
- Immunology/Inflammation Compound Library
- Metabolism/Protease Compound Library
- NF-κB Signaling Compound Library
- Natural Product Library
- Anti-Cancer Compound Library
- Anti-Aging Compound Library
- Covalent Screening Library
- Antioxidants Compound Library
- Oxygen Sensing Compound Library
- Traditional Chinese Medicine Monomer Library
- Neuroprotective Compound Library
- Food-Sourced Compound Library
- Targeted Diversity Library
生物活性 |
Curcumenol ((+)-Curcumenol) is a potent CYP3A4 inhibitor with an IC50 of 12.6 μM, which is one of constituents in the plants of medicinally important genus of Curcuma zedoaria, with neuroprotection, anti-inflammatory, anti-tumor and hepatoprotective activities. Curcumenol ((+)-Curcumenol) suppresses Akt-mediated NF-κB activation and p38 MAPK signaling pathway in LPS-stimulated BV-2 microglial cells[1][2]. |
IC50 & Target |
IC50:12.6 μM (CYP3A4)[1] |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
分子量 |
234.33 |
||||||||||||||||
Formula |
C15H22O2 |
||||||||||||||||
CAS 号 |
19431-84-6 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
|
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 125 mg/mL (533.44 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|
||||||||||||||||
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务